in ,

WHO nod for Covaxin expected by month-end: Bharat Biotech

News Agencies

New Delhi, Sept 13: Approval for Bharat Biotech’s Covid-19 vaccine Covaxin in the emergency use list (EUL) by the World Health Organisation (WHO) is expected by the end of this month, sources in the company said on Monday, adding that “all queries have been answered”.

As per WHO guidelines, emergency use listing (EUL) is a procedure to streamline the process in which new products can be approved and used during public health emergencies like a pandemic.

Last month, Union Health Minister Mansukh Mandaviya had met WHO Chief Scientist Dr Soumya Swaminathan and held discussions over the global health body’s approval for Covaxin.

“Held a meeting with Dr Soumya Swaminathan, Chief Scientist of @WHO. We had a productive discussion on WHO’s approval of @BharatBiotech’s COVAXIN. @DoctorSoumya also appreciated India’s efforts for the containment of #COVID19,” Mandaviya had tweeted.

Bharat Biotech had in July submitted all documents required for EUL of Covaxin to the WHO.

Developed by Bharat Biotech in partnership with National Institute of Virology and the Indian Council of Medical Research, Covaxin was approved for emergency use on January 3. Trial results later showed the vaccine has an efficacy of 78 per cent.

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0

Ford’s India exit: This is how used car business will be affected

Tamil Nadu assembly passes Bill for medical admissions without NEET